InsuTAG: A novel physiologically relevant predictor for insulin resistance and metabolic syndrome
暂无分享,去创建一个
M. Garg | R. Thota | K. Abbott | M. Veysey | M. Lucock | S. Niblett | Katrina King | J. Ferguson
[1] J. Romijn,et al. Methods for quantifying adipose tissue insulin resistance in overweight/obese humans , 2017, International Journal of Obesity.
[2] L. Hsu,et al. Triglyceride Glucose-Body Mass Index Is a Simple and Clinically Useful Surrogate Marker for Insulin Resistance in Nondiabetic Individuals , 2016, PloS one.
[3] M. Garg,et al. Sex-dependent association between erythrocyte n-3 PUFA and type 2 diabetes in older overweight people. , 2016, The British journal of nutrition.
[4] D. Simonson. Surrogate measures of insulin resistance: does one size fit all? , 2015, Diabetologia.
[5] Xuefeng Yu,et al. O R I G I N a L I N V E S T I G a T I O N Open Access , 2022 .
[6] M. Laakso,et al. Insulin resistance and hyperglycaemia in cardiovascular disease development , 2014, Nature Reviews Endocrinology.
[7] Jingyuan Fu,et al. Are hypertriglyceridemia and low HDL causal factors in the development of insulin resistance? , 2014, Atherosclerosis.
[8] L. Guoping,et al. Triglyceride-to-HDL cholesterol ratio , 2013, Herz.
[9] K. Adeli,et al. Selective Hepatic Insulin Resistance, VLDL Overproduction, and Hypertriglyceridemia , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[10] L. Gormsen,et al. Increased VLDL-Triglyceride Secretion Precedes Impaired Control of Endogenous Glucose Production in Obese, Normoglycemic Men , 2011, Diabetes.
[11] S. Caprio,et al. The Triglyceride-to-HDL Cholesterol Ratio , 2011, Diabetes Care.
[12] M. Rodríguez-Moran,et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. , 2010, The Journal of clinical endocrinology and metabolism.
[13] Bhawna Singh,et al. Surrogate markers of insulin resistance: A review. , 2010, World journal of diabetes.
[14] C. Lassale,et al. Estimating food intakes in Australia: validation of the Commonwealth Scientific and Industrial Research Organisation (CSIRO) food frequency questionnaire against weighed dietary intakes. , 2009, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.
[15] K. Adeli,et al. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. , 2009, Clinical biochemistry.
[16] Richard Kahn,et al. Relationship of Insulin Resistance and Related Metabolic Variables to Coronary Artery Disease: A Mathematical Analysis , 2009, Diabetes Care.
[17] P. Nilsson,et al. Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes , 2007, Journal of Human Hypertension.
[18] M. Laakso,et al. Lipids and glucose in type 2 diabetes: what is the cause and effect? , 2004, Diabetes care.
[19] Tracey McLaughlin,et al. Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant , 2003, Annals of Internal Medicine.
[20] H. Kahn,et al. Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration. , 2003, The American journal of clinical nutrition.
[21] D. Chisholm,et al. Multiple indexes of lipid availability are independently related to whole body insulin action in healthy humans. , 2003, The Journal of clinical endocrinology and metabolism.
[22] C. Kahn,et al. Insulin signalling and the regulation of glucose and lipid metabolism , 2001, Nature.
[23] M. Laakso,et al. Insulin resistance syndrome predicts coronary heart disease events in elderly type 2 diabetic men. , 2001, Diabetes care.
[24] W. Harris,et al. n-3 fatty acids and serum lipoproteins: animal studies. , 1997, The American journal of clinical nutrition.
[25] G. Mingrone,et al. Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids , 1997, Diabetologia.
[26] W. Harris,et al. n-3 fatty acids and urinary excretion of nitric oxide metabolites in humans. , 1997, The American journal of clinical nutrition.
[27] A. Krolewski,et al. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. , 1990, Annals of internal medicine.
[28] G. Reaven. Role of Insulin Resistance in Human Disease , 1988, Diabetes.
[29] G. Reaven. Banting lecture 1988. Role of insulin resistance in human disease. , 1988, Diabetes.
[30] B V Howard,et al. Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. , 1988, The New England journal of medicine.
[31] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[32] R. DeFronzo,et al. Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.
[33] M. Garg,et al. Association between omega-3 index and blood lipids in older Australians. , 2016, The Journal of nutritional biochemistry.
[34] W. Harris,et al. n-3 fatty acids and serum lipoproteins: human studies. , 1997, The American journal of clinical nutrition.